RN486

Target: This ligand targets Bruton tyrosine kinase (BTK) in biochemical or cellular target-engagement studies.

Mechanism of Action: Used as the target-protein recognition element, this ligand provides the binding interface for Bruton tyrosine kinase (BTK). In PROTAC design, a derivatizable position on the ligand can be connected through an optimized linker to an E3 ligase ligand, such as a CRBN, VHL, or IAP recruiter, while preserving productive target engagement. The resulting bifunctional molecule brings Bruton tyrosine kinase (BTK) into proximity with the recruited E3 ligase, enabling ternary-complex formation. If the complex has favorable geometry and residence time, target lysine ubiquitination is promoted, leading to proteasome-dependent degradation in experimental systems.

• PROTAC Design for RN486: RN486 can be used as a ligand component in PROTAC constructs to recruit a chosen E3 ligase and drive proximity-induced ubiquitination of the target protein. This enables systematic optimization of linker length, attachment position, and stereochemistry to maximize target engagement and degradation potency in cellular degradation assays.

• Targeted Protein Degradation Studies: RN486-based PROTACs are suitable for investigating degradation kinetics, including onset time, dose–response relationships, and recovery after washout. By quantifying target protein loss via immunoblotting or proteomics, researchers can distinguish degraders from inhibitors and map how ligand affinity and E3 recruitment efficiency shape degradation outcomes.

• Mechanism-of-Action Validation: RN486 PROTACs can support mechanistic studies using E3 ligase perturbation, proteasome inhibition, and ubiquitination readouts. These experiments help confirm that RN486-mediated recruitment leads to proteasome-dependent degradation, identify the ubiquitin linkage patterns involved, and clarify whether degradation is driven by productive ternary complex formation.

• Optimization of Ternary Complex Formation: RN486 can be leveraged to tune PROTAC geometry for improved ternary complex stability between the target protein and the E3 ligase. Researchers can compare series of RN486-derived conjugates to evaluate how changes in linker flexibility and spatial orientation affect ternary complex dwell time, degradation selectivity, and resistance to competing ligands.

RN486 is a BTK kinase target ligand intended for use as the target-engaging component or reference ligand in PROTAC discovery workflows. Its known small-molecule recognition profile enables rational linker-vector evaluation and comparative degrader design. This molecule is described in detail below.

Structure: The structure of RN486 is characterized by primary or secondary amine/basic nitrogen centers; phenol or alcohol functionality; halogenated aryl/heteroaryl ring system; heteroaromatic protein-recognition scaffold. These features provide defined hydrogen-bonding, hydrophobic, and steric elements that can support affinity retention while enabling analogue-based linker-vector selection.

Reactivity: The amine/basic nitrogen-containing motif can be evaluated for acylation, sulfonylation, alkylation, or carbamate/urea linker installation when that vector is solvent exposed. For PROTAC construction, the POI ligand can be paired with CRBN ligands such as thalidomide, pomalidomide, or lenalidomide analogues, VHL ligands such as VH032 derivatives, or less common IAP/MDM2/cIAP-recruiting ligands, with alkyl, PEG, piperazine, triazole, or amide linkers screened for ternary-complex formation. In practice, incorporation into PROTACs should begin from derivatives that preserve the reported binding pharmacophore, followed by systematic variation of linker length, polarity, rigidity, and exit-vector geometry to optimize target engagement, E3 recruitment, and cellular degradation readouts.